{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-24-000345","form_type":"8-K","ticker":"ARTL","cik":"0001621221","company_name":"ARTELO BIOSCIENCES, INC.","filed_at":"2024-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.839213+00:00","generated_at":"2026-06-05T04:45:06.512873+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Artelo Biosciences reprices options to $1.55, resets vesting over 3 years for retention","bullets":["Compensation Committee amends options with exercise price ≥$1.99 to new price of $1.55 (Feb 28 closing).","New vesting: 1/3 vests on first anniversary, then 1/36 monthly; all previously unvested shares reset.","CEO Greg Gorgas holds 274,308 option shares with original range $3.15-$39.90 affected.","Change applies to employees and non-employee directors; no new dilution from additional grants.","Company aims to retain key contributors while preserving cash resources."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-24-000345","json":"https://secwatch.observer/filing/0001640334-24-000345.json","markdown":"https://secwatch.observer/filing/0001640334-24-000345.md","text":"https://secwatch.observer/filing/0001640334-24-000345.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1621221/000164033424000345/0001640334-24-000345-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1621221/000164033424000345/artl_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T04:45:06.512873+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}